Cigarette smoking and the risk of Barrett's esophagus: A systematic review and meta-analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 8, 2013, Pages 1258-1273

  Andrici, Juliana ^a   Cox, Michael R ^a   Eslick, Guy D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Barrett's esophagus; Cigarettes; Meta analysis; Smoking; Tobacco

Indexed keywords

AGE; ALCOHOL CONSUMPTION; BARRETT ESOPHAGUS; BODY MASS; COHORT ANALYSIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GENDER; HEARTBURN; HUMAN; INTESTINE METAPLASIA; META ANALYSIS; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SMOKING; SYSTEMATIC REVIEW; TOBACCO;

EID: 84880694351     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12230     Document Type: Review

References (75)

1. Spechler JS. Barrett's esophagus. N. Engl. J. Med. 2002; 346: 836-842.
2. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol. 2008; 103: 788-797.
3. Lagergren J, Bergström R, Lindgren A etal. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 1999; 340: 825-831.
4. Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br. J. Cancer 2009; 101: 855-859.
5. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-2053.
6. Lepage C, Rachet B, Jooste V etal. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am. J. Gastroenterol. 2008; 103: 2694-2699.
7. Bosetti C, Levi F, Ferlay J etal. Trends in oesophageal cancer incidence and mortality in Europe. Int. J. Cancer 2008; 122: 1118-1129.
8. Ronkainen J, Aro P, Storskrubb T etal. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129: 1825-1831.
9. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol. Clin. North Am. 1997; 26: 487-494.
10. Hirota WK, Loughney TM, Lazas DJ etal. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277-285.
11. Edelstein ZR, Farrow DC, Bronner MP etal. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007; 133: 403-411.
12. DeMeester SR. Barrett's esophagus. Curr. Probl. Surg. 2001; 38: 549-640.
13. Kamangar K, Chow WH, Abnet C etal. Environmental causes of esophageal cancer. Gastroenterol. Clin. North Am. 2009; 38: 27-57.
14. Cook MB, Kamangar F, Whiteman DC etal. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J. Natl Cancer Inst. 2010; 102: 1344-1353.
15. Avidan B, Sonnenberg A, Schnell TG etal. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Dig. Dis. Sci. 2002; 47: 256-264.
16. Edelstein ZR, Bronner MP, Rosen SN etal. Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. Am. J. Gastroenterol. 2009; 104: 834-842.
17. Smith KJ, O'Brien SM, Green AC etal. Current and past smoking significantly increase risk for Barrett's esophagus. Clin. Gastroenterol. Hepatol. 2009; 7: 840-848.
18. Anderson LA, Watson RG, Murphy SJ etal. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J. Gastroenterol. 2007; 13: 1585-1594.
19. Fouad YM, Makhlouf MM, Tawfik HM etal. Barrett's esophagus: prevalence and risk factors in patients with chronic GERD in Upper Egypt. World J. Gastroenterol. 2009; 15: 3511-3515.
20. Avidan B, Sonnonberg A, Schnell T etal. Gastric surgery is not a risk for Barrett's esophagus or esophageal adenocarcinoma. Gastroenterology 2001; 121: 1281-1285.
21. Chacaltana A, Urday C, Ramon W etal. [Prevalence, clinical-endoscopic characteristics and predictive factors of Barrett's Esophagus in endoscopic screening for gastric cancer.] Rev. Gastroenterol. Peru. 2009; 29: 24-32. (Article in Spanish.)
22. Solaymani-Dodaran M, Logan RF, West J etal. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastrooesophageal reflux. Scand. J. Gastroenterol. 2004; 39: 680-685.
23. Cook MB, Shaheen NJ, Anderson LA etal. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology 2012; 142: 744-753.
24. Enzinger PC, Mayer RJ. Esophageal cancer. N. Engl. J. Med. 2003; 349: 2241-2252.
25. Stroup DF, Berlin JA, Morton SC etal. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008-2012.
26. Akiyama T, Inamori M, Akimoto K etal. Risk factors for the progression of endoscopic Barrett's epithelium in Japan: a multivariate analysis based on the Prague C & M criteria. Dig. Dis. Sci. 2009; 54: 1702-1707.
27. Cauvin JM, Goldfain D, Le Rhun M etal. Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Lancet 1995; 346: 1391-1394.
28. Gray MR, Donnelly RJ, Kingsnorth AN. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut 1993; 34: 727-731.
29. Matsuzaki J, Suzuki H, Asakura K etal. Gallstones increase the prevalence of Barrett's esophagus. J. Gastroenterol. 2010; 45: 171-178.
30. Ritenbaugh C, Sampliner R, Aickin M etal. Risk factors for Barrett's oesophagus: a life history approach to behavioural assessment in the distant past. Eur. J. Cancer Prev. 1995; 4: 459-468.
31. Caygill CPJ, Johnston DA, Lopez M etal. Lifestyle factors and Barrett's esophagus. Am. J. Gastroenterol. 2002; 97: 1328-1331.
32. Vaughan TL, Dong LM, Blount PL etal. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol. 2005; 6: 945-952.
33. Smith KJ, O'Brien SM, Smithers BM etal. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol. Biomarkers Prev. 2005; 14: 2481-2486.
34. Kim JH, Rhee P-L, Lee JH. Prevalence and risk factors of Barrett's esophagus in Korea. J. Gastroenterol. Hepatol. 2007; 22: 908-912.
35. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-188.
36. Higgins JP, Thompson SG, Deeks JJ etal. Measuring inconsistency in meta-analyses. Br. Med. J. 2003; 327: 557-560.
37. Egger M, Davey S, Schneider M etal. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 1997; 315: 629-634.
38. Orwin R. A fail-safe N for effect size in meta-analysis. J. Educ. Stat. 1983; 8: 157-159.
39. Casson AG, Zheng Z, Porter AP etal. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Cancer Detect. Prev. 2006; 30: 423-431.
40. Conio M, Filiberti R, Blanchi S etal. Risk factors for Barrett's esophagus: a case-control study. Int. J. Cancer 2002; 97: 225-229.
41. Dhawan PS, Alvares JF, Vora IM etal. Prevalence of short segments of specialized columnar epithelium in the distal esophagus: association with gastroeesophageal reflux. Indian J. Gastroenterol. 2001; 20: 144-147.
42. di Martino E, Hardie LJ, Wild CP etal. The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma. Genet. Med. 2007; 9: 341-347.
43. Eloubeidi MA, Provenzale D. Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J. Clin. Gastroenterol. 2001; 33: 306-309.
44. Ferrandez A, Benito R, Arenas J etal. CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate. BMC Gastroenterol. 2006; 6: 7-16.
45. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 46-47.
46. Gerson LB, Ullah N, Fass R etal. Does body mass index differ between patients with Barrett's oesophagus and patients with chronic gastro-oesophageal reflux disease? Aliment. Pharmacol. Ther. 2007; 25: 1079-1086.
47. Gerson LB, Banerjee S. Screening for Barrett's esophagus in asymptomatic women. Gastrointest. Endosc. 2009; 70: 867-873.
48. Ibiebele TI, Hughes MC, Pandeya N etal. High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population. J. Nutr. 2011; 141: 274-283.
49. Jacobson BC, Giovannucci EL, Fuchs CS. Smoking and Barrett's esophagus in women who undergo upper endoscopy. Dig. Dis. Sci. 2011; 56: 1707-1717.
50. Johansson J, Hakansson HO, Mellblom L etal. Risk factors for Barrett's oesophagus: a population-based approach. Scand. J. Gastroenterol. 2007; 42: 148-156.
51. Johnston MH, Hammond AS, Laskin W etal. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am. J. Gastroenterol. 1996; 91: 1507-1510.
52. Jonaitis L, Kriukas D, Kiudelis G etal. Risk factors for erosive esophagitis and Barrett's esophagus in a high Helicobacter pylori prevalence area. Medicina (Kaunas) 2011; 47: 434-439.
53. Kicinski P, Mokrowiecka A, Czkwianianc E etal. [The role of selected risk factors in Barrett's esophagus development.] Pol. Merkur. Lekarski. 2009; 26: 390-394. (Article in Polish.)
54. Kubo A, Levin TR, Block G etal. Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology 2009; 136: 806-815.
55. Kubo A, Levin TR, Block G etal. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control 2009; 20: 303-311.
56. Kuo CJ, Lin CH, Liu NJ etal. Frequency and risk factors for Barrett's esophagus in Taiwanese patients: a prospective study in a tertiary referral center. Dig. Dis. Sci. 2010; 55: 1337-1343.
57. Lam KD, Phan JT, Garcia RT etal. Low proportion of Barrett's esophagus in Asian Americans. Am. J. Gastroenterol. 2008; 103: 1625-1630.
58. Mathew P, Joshi A, Shukla A etal. Risk factors for Barrett's esophagus in Indian patients with gastroesophageal reflux disease. J. Gastroenterol. Hepatol. 2011; 26: 1151-1156.
59. Olliver JR, Hardie LJ, Gong Y etal. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Cancer Epidemiol. Biomarkers Prev. 2005; 14: 620-625.
60. Park J-J, Kim JW, Kim HJ etal. The prevalence and risk factors for Barrett's esophagus in a Korean population. J. Clin. Gastroenterol. 2009; 43: 907-914.
61. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig. Dis. Sci. 2004; 49: 237-242.
62. Rajendra S, Ackroyd R, Robertson IK etal. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East. Helicobacter 2007; 12: 177-183.
63. Rubenstein JH, Dahlkemper A, Kao JY. Pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am. J. Gastroenterol. 2008; 103: 1358-1364.
64. Siersema PD, Yu S, Sahbaie P etal. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest. Endosc. 2006; 63: 581-586.
65. Steevens J, Schouten LJ, Goldbohm RA etal. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 2010; 59: 39-48.
66. Tseng PH, Lee YC, Hhiu HM etal. Prevalence and clinical characteristics of Barrett's esophagus in a Chinese general population. J. Clin. Gastroenterol. 2008; 42: 1074-1079.
67. Veugelers PJ, Porter GA, Guernsey DL etal. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis. Esophagus 2006; 19: 321-328.
68. Smit CF, Copper MP, van Leeuwen JA etal. Effect of cigarette smoking on gastropharyngeal and gastroesophageal reflux. Ann. Otol. Rhinol. Laryngol. 2001; 110: 190-193.
69. Kahrilas PJ, Gupta RR. Mechanisms of acid reflux associated with cigarette smoking. Gut 1990; 31: 4-10.
70. Fischbach LA, Nordenstedt H, Kramer JR etal. The association between Barrett's esophagus and helicobacter pylori infection: a meta-analysis. Helicobacter 2012; 17: 163-175.
71. Audrain-McGovern J, Benowitz NL. Cigarette smoking, nicotine, and body weight. Clin. Pharmacol. Ther. 2011; 90: 164-168.
72. Chiolero A, Faeh D, Paccaud F etal. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am. J. Clin. Nutr. 2008; 87: 801-809.
73. John U, Hanke M, Rumpf HJ etal. Smoking status, cigarettes per day, and their relationship to overweight and obesity among former and current smokers in a national adult general population sample. Int. J. Obes. Relat. Metab. Disord. 2005; 29: 1289-1294.
74. Chiolero A, Jacot-Sadowski I, Faeh D etal. Association of cigarettes daily smoked with obesity in a general European adult population. Obes. Res. 2007; 15: 1311-1318.
75. Brigham J, Lessov-Schlaggar CN, Javitz HS etal. Reliability of adult retrospective recall of lifetime tobacco use. Nicotine Tob. Res. 2008; 10: 287-299.